Adenosina Hikma

Adenosina Hikma is a pharmaceutical product containing adenosine, used for intravenous administration. It is manufactured by Hikma Farmacêutica (Portugal), S.A. and is commonly associated with cardiac applications.

Adenosina Hikma is primarily used in medical settings for its effects on the heart. It is often utilized to convert certain types of abnormal heart rhythms back to normal. The drug works by slowing down electrical signals in the heart, which can help restore a regular heartbeat. Adenosine is also used to diagnose certain heart conditions by evaluating the heart's response to the medication.

When administered intravenously, Adenosina Hikma can cause a temporary slowing of the heart rate. This effect is usually short-lived and is part of its intended action. Some individuals may experience flushing, shortness of breath, or chest discomfort during administration. These effects are generally mild and resolve quickly.

Adenosina Hikma should be used under the supervision of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before administration. The medication should be handled with care, ensuring it is stored and administered according to the prescribed guidelines.

Adenosina Hikma may interact with certain medications, including those used to treat heart conditions or stimulate the heart. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, caffeine and other stimulants may affect the efficacy of adenosine.